ASX:FPH - Fisher & Paykel Healthcare Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started A$15.63 +0.18 (+1.17 %) (As of 05/23/2019 05:25 AM ET)Previous CloseA$15.45Today's RangeA$15.39 - A$15.6752-Week RangeA$11.28 - A$15.55Volume257,436 shsAverage Volume371,449 shsMarket Capitalization$8.94 billionP/E Ratio63.80Dividend Yield1.22%BetaN/A ProfileChartDividendInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, and markets medical device products and systems worldwide. The company offers its products for use in respiratory, acute care, and surgery; and for the treatment of obstructive sleep apnea (OSA). It operates through four segments: New Zealand, North America, Europe, and Asia-Pacific. The company offers adult respiratory products, such as AIRVO 2 system, a humidifier with integrated flow source; Optiflow, a nasal high flow therapy; and noninvasive and invasive ventilation systems. It also provides infant respiratory products, including resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. In addition, the company offers surgical humidification systems; and homecare products comprising masks, CPAP devices, data management, humidifiers, and accessories. It markets and sells its products through its distribution subsidiaries, third party distributors, and original equipment manufacturers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand. Receive FPH News and Ratings via Email Sign-up to receive the latest news and ratings for FPH and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange ASX Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolASX:FPH Previous Symbol CUSIPN/A CIKN/A Webhttp://www.fphcare.com/ Phone+64-9-5740100Debt Debt-to-Equity Ratio12.36 Current Ratio2.08 Quick Ratio1.35Price-To-Earnings Trailing P/E Ratio63.80 Forward P/E Ratio44.66 P/E GrowthN/A Sales & Book Value Annual Sales$707.99 million Price / Sales12.63 Cash FlowA$0.16 per share Price / Cash Flow99.62 Book ValueA$0.93 per share Price / Book16.81Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees4,000 Outstanding Shares572,060,032Market Cap$8.94 billion Next Earnings DateN/A OptionableNot Optionable Fisher & Paykel Healthcare (ASX:FPH) Frequently Asked Questions What is Fisher & Paykel Healthcare's stock symbol? Fisher & Paykel Healthcare trades on the ASX under the ticker symbol "FPH." How often does Fisher & Paykel Healthcare pay dividends? What is the dividend yield for Fisher & Paykel Healthcare? Fisher & Paykel Healthcare announced a Interim dividend on Tuesday, November 27th. Investors of record on Friday, December 21st will be given a dividend of 0.092 per share on Friday, December 21st. This represents a yield of 0.73%. The ex-dividend date of this dividend is Friday, December 7th. View Fisher & Paykel Healthcare's Dividend History. Has Fisher & Paykel Healthcare been receiving favorable news coverage? Media headlines about FPH stock have trended positive this week, according to InfoTrie Sentiment. The research firm identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Fisher & Paykel Healthcare earned a media sentiment score of 2.7 on InfoTrie's scale. They also gave headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the near future. Who are some of Fisher & Paykel Healthcare's key competitors? Some companies that are related to Fisher & Paykel Healthcare include Cochlear (COH), ConvaTec Group (CTEC), Inspire Medical Systems (INSP), Draegerwerk AG & Co KGaA (DRW3), Avita Medical (AVH), Stratec (SBS), Creo Medical Group (CREO), Medica Group (MGP), Hamilton Thorne (HTL), Titan Medical (TMD), Advanced Oncotherapy (AVO), Cyclopharm (CYC), Helius Medical Technologies (HSM), Kromek Group (KMK) and Impedimed (IPD). What other stocks do shareholders of Fisher & Paykel Healthcare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Fisher & Paykel Healthcare investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Blackmores (BKL), Credit Corp Group (CCP), Arbutus Biopharma (ABUS), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Apellis Pharmaceuticals (APLS), Aquinox Pharmaceuticals (AQXP) and Ardelyx (ARDX). Who are Fisher & Paykel Healthcare's key executives? Fisher & Paykel Healthcare's management team includes the folowing people: Mr. Lewis G. Gradon, MD, CEO & Exec. Director (Age 58)Ms. Andrea Blackie, Acting Chief Financial OfficerDr. Andrew Somervell, VP of Products & TechnologyRachel Reynolds, Sr. Communications Mang.Mr. Paul N. Shearer, Sr. VP of Sales & Marketing What is Fisher & Paykel Healthcare's stock price today? One share of FPH stock can currently be purchased for approximately A$15.63. How big of a company is Fisher & Paykel Healthcare? Fisher & Paykel Healthcare has a market capitalization of $8.94 billion and generates $707.99 million in revenue each year. Fisher & Paykel Healthcare employs 4,000 workers across the globe. What is Fisher & Paykel Healthcare's official website? The official website for Fisher & Paykel Healthcare is http://www.fphcare.com/. How can I contact Fisher & Paykel Healthcare? Fisher & Paykel Healthcare's mailing address is 15 Maurice Paykel Place, East Tamaki, AUCKLAND, 1061, New Zealand. The company can be reached via phone at +64-9-5740100. MarketBeat Community Rating for Fisher & Paykel Healthcare (ASX FPH)Community Ranking: 2.2 out of 5 ( )Outperform Votes: 43 (Vote Outperform)Underperform Votes: 57 (Vote Underperform)Total Votes: 100MarketBeat's community ratings are surveys of what our community members think about Fisher & Paykel Healthcare and other stocks. Vote "Outperform" if you believe FPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FPH will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/23/2019 by MarketBeat.com StaffFeatured Article: Compound Interest Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.